Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma. | Front Oncol | 2022 | 35359374 | PubTator, text mining | PubMed |
| Epigenetic downregulation of Socs2 contributes to mutant N-Ras-mediated hematopoietic dysregulation. | Dis Model Mech | 2022 | 35352806 | PubTator, text mining | PubMed |
Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. | Front Genet | 2022 | 35350243 | PubTator, text mining | PubMed |
| Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse. | J Clin Invest | 2022 | 35349491 | PubTator, text mining | PubMed |
| Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection. | Viruses | 2022 | 35336991 | PubTator, text mining | PubMed |
| Recent Advances of Point-of-Care Devices Integrated with Molecularly Imprinted Polymers-Based Biosensors: From Biomolecule Sensing Design to Intraoral Fluid Testing. | Biosensors (Basel) | 2022 | 35323406 | PubTator, text mining | PubMed |
| Chemokine CCL17 Affects Local Immune Infiltration Characteristics and Early Prognosis Value of Lung Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35321241 | PubTator, text mining | PubMed |
| Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders. | Nat Rev Drug Discov | 2022 | 35314852 | PubTator, text mining | PubMed |
| 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas. | Front Immunol | 2022 | 35309316 | PubTator, text mining | PubMed |
| Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer Cells. | Front Immunol | 2022 | 35300331 | PubTator, text mining | PubMed |
| Development and Validation of a Ferroptosis-Related lncRNAs Prognosis Model in Oral Squamous Cell Carcinoma. | Front Genet | 2022 | 35299954 | PubTator, text mining | PubMed |
| The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia. | Blood Adv | 2022 | 35298613 | PubTator, text mining | PubMed |
| Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus. | Aliment Pharmacol Ther | 2022 | 35292991 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development. | Cancer Med | 2022 | 35285582 | PubTator, text mining | PubMed |
| Analysis of the long non-coding RNA and mRNA expression profiles associated with lidocaine-induced neurotoxicity in the spinal cord of a rat model. | Neurotoxicology | 2022 | 35283115 | PubTator, text mining | PubMed |
| Signaling Pathways Tuning Innate Lymphoid Cell Response to Hepatocellular Carcinoma. | Front Immunol | 2022 | 35281021 | PubTator, text mining | PubMed |
| Regulatory T Cells: Angels or Demons in the Pathophysiology of Sepsis? | Front Immunol | 2022 | 35281010 | PubTator, text mining | PubMed |
| Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients. | Front Immunol | 2022 | 35281000 | PubTator, text mining | PubMed |
| Cromolyn Sodium differentially regulates human mast cell and mouse leukocyte responses to control allergic inflammation. | Pharmacol Res | 2022 | 35278626 | PubTator, text mining | PubMed |
| Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma. | Bosn J Basic Med Sci | 2022 | 35276059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=50